Allogeneic stem cell transplantation as a treatment for non-malignant diseases;Allogen stamcelletransplantation ved ikkemaligne sygdomme

Ugeskrift for Laeger

Volumn 165, Issue 50, 2003, Pages 4850-4852

  Heilmann, Carsten Johan ^a   Jacobsen, Niels ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

ALLOGRAFT; APLASTIC ANEMIA; CONGENITAL ADRENAL HYPERPLASIA; DENMARK; EOSINOPHILIA MYALGIA SYNDROME; FANCONI ANEMIA; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; SHORT SURVEY; STEM CELL TRANSPLANTATION; THALASSEMIA MAJOR; TREATMENT INDICATION;

ANEMIA, APLASTIC; BETA-THALASSEMIA; GENETIC DISEASES, INBORN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

EID: 1642569696     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Frickhofen N, Heimpel H, Kaltwasser JP et al. Antithymocyte globulin with or without cyclosporin. Blood 2003;10:1236-42.
2. Bacigalupo A, Brand R, Oneto R et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy. The European Group for Blood and Marrow Transplantation experience. Semin Hematol 2000;37:69-80.
3. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994;84:941-9.
4. Bacigalupo A, Oneto R, Bruno B et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow Transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol 2000;103:19-25.
5. Olivieri NF. The beta-thalassemias. N Engl J Med 1999; 341:99-109.
6. Lucarelli G, Galimberti M, Giardini C et al. Bone marrow transplantation in thalassemia. Ann N Y Acad Sci 1998; 850:270-5.
7. Antoine C, Müller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003;361:553-60.
8. Alter BP. Cancer in Fanconi anemia. 1927-2001. Cancer 2003; 97:425-40.
9. Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86:2856-62.
10. Guardiola P, Pasquini R, Dolkal I et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95:422-9.
11. Krivit W. Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv Pediatr 2002;49:359-78.
12. Gluckman E, Broxmeyer HE, Auerbach AD. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321:1174-8.
13. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.
14. Jacobsen N, Taaning E, Ladefoged J et al. Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from the same donor. Lancet 1994;i:800-1.